T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Healthcare | 16.24% |
| 3 | Consumer Discretionary | 15.33% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Westlake Corp
WLK
$10.2B
| $113M | 0.01% |
1,238,381
-804,893
| -39% | -$68.9M |
|
727
Tyler Technologies
TYL
$12.8B
| $112M | 0.01% |
244,491
-5,978
| -2% | -$2.85M |
|
728
TransDigm Group
TDG
$68.5B
| $112M | 0.01% |
179,387
+21,982
| +14% | +$13.7M |
|
729
Exponent
EXPO
$3.2B
| $112M | 0.01% |
988,933
-4,903
| -0.5% | -$529K |
|
730
Allogene Therapeutics
ALLO
$704M
| $112M | 0.01% |
4,338,991
+803,807
| +23% | +$19.1M |
|
731
Twist Bioscience
TWST
$7.79B
| $111M | 0.01% |
1,038,758
-5,998
| -0.6% | -$687K |
|
732
Edwards Lifesciences
EW
$53.4B
| $110M | 0.01% |
975,121
-15,517
| -2% | -$1.77M |
|
|
AEPPL
733
DELISTED
American Electric Power Company, Inc. Corporate Unit
AEPPL
| $110M | 0.01% |
2,296,416
-926,450
| -29% | -$46.4M |
|
734
Toast
TOST
$19.9B
| $110M | 0.01% |
+2,205,603
| New | +$121M |
|
735
Illumina
ILMN
$28.8B
| $109M | 0.01% |
277,443
+10,867
| +4% | +$5M |
|
736
SPS Commerce
SPSC
$2.72B
| $109M | 0.01% |
677,554
-54,877
| -7% | -$6.76M |
|
737
Boston Omaha
BOC
$431M
| $109M | 0.01% |
2,816,485
-8,744
| -0.3% | -$289K |
|
738
PagSeguro Digital
PAGS
$2.42B
| $109M | 0.01% |
2,108,667
-1,659,096
| -44% | -$93.1M |
|
|
ELME
739
Elme Communities
ELME
$145M
| $109M | 0.01% |
4,394,118
+759,487
| +21% | +$18.7M |
|
740
Primerica
PRI
$9.59B
| $109M | 0.01% |
707,777
-21,132
| -3% | -$3.14M |
|
741
Occidental Petroleum
OXY
$57.5B
| $109M | 0.01% |
3,670,303
+2,055
| +0.1% | +$54.9K |
|
742
Floor & Decor
FND
$6.27B
| $108M | 0.01% |
897,623
+177,556
| +25% | +$21.2M |
|
743
Certara
CERT
$1.22B
| $108M | 0.01% |
3,267,329
-15,626
| -0.5% | -$472K |
|
744
Capri Holdings
CPRI
$1.79B
| $108M | 0.01% |
2,232,337
+156,898
| +8% | +$8.55M |
|
|
DIDI
745
DELISTED
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
| $107M | 0.01% |
3,630,462
-6,584,229
| -64% | -$62.1M |
|
746
KT
KT
$9.09B
| $107M | 0.01% |
7,876,195
-15,600
| -0.2% | -$221K |
|
747
Alamo Group
ALG
$2.01B
| $107M | 0.01% |
766,950
+16,397
| +2% | +$2.41M |
|
748
CTS Corp
CTS
$1.81B
| $107M | 0.01% |
3,460,444
-57,112
| -2% | -$1.96M |
|
|
SGI
749
Somnigroup International
SGI
$13.9B
| $107M | 0.01% |
2,304,045
-49,279
| -2% | -$2.15M |
|
750
Surgery Partners
SGRY
$1.99B
| $107M | 0.01% |
2,525,436
-160,058
| -6% | -$8.17M |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.